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Progressive Encephalopathy and Myopathy in 
Transgenie Mice Expressing Human Foamy VtnJS Genes 
KATRIN Bonm, AnRIANo AGuzzi, HANs LAssMANN, 
AxEL RETIIWILM, lvAN HoRAK* 
Transgenie mice carrying the bel region of human foamy retrovirus (HFV) under 
transcriptional control of its own long terminal repeat expressed tbe transgene in tbeir 
centrat nervous systems and in smootb and striated muscle tissues. The animals 
developed a progressive degenerative disease of tbe centrat nervous system and of tbe 
striated muscle. Because expression of tbe transgene was dosely correlated witb tbe 
appearance of structural damage and inflammatory reactions were scanty, the disease 
is likely to be caused directly by tbe HFV proteins. These unexpected findings call for 
a reevaluation of tbe patbogenic potential of HFV in bumans. 
H FV ISA RETROVIRUS ORIGINALLY isolated 20 years ago from individ:-uals with various diseases {1, 2). 
Although the prevalence of HFV was re-
ported to be high in certain geographical 
areas (3}, it has not been possible to identify 
HFV as the causative agent of any human 
disease ( 4). As with the human T cdl Iym-
phoma virus (Hil.. V) and human immunode-
ficiency virus (lflV), the HFV genome has, in 
addition to structura1 retroviral genes, a region 
oontaining three open reading frames, bel-1 to 
bel-3. Bel-l has some homology to IDV-2 Tat 
prorein and, similarly to lllV Tat and Hil.. V -I 
Tax, functions as a transaiptional transaaiva-
tor (~). 
form because of a frameshift mutation in the 
integrase domain that created a premature 
stop codon in pol, and (ii) p~gpe, in which 
2.3 kb of gag-pol and 1.6 kb of env were 
de1ettd (7) (Fig. IA). In both oonstructs, 
expression is oontrolled by the HFV long ter-
minal repeat (LTR). Eight and nine f01mder 
animals ( 11) were daived with pHFV M and 
p~gpe, respectively. Five pHFV M and six 
p~gpe mice developed a neurological syn-
drome oonsisting of ataxia, spastic tetraparesis~ 
and blindness. The symptoms in the pHFV M 
mice appeared as early as 5 to 6 weeks after 
birth, progressed rapidly, and led to death 
within 4 to 6 weeks. The p4gpe transgenic 
mice displayed a later onset of the disease (1 to 
Flg. 1. (A) Gcnomic organization of HFV and 
comtruas uscd for microinjection. Both con-
struas have been shown to t:ransactivale HFV 
transcription in cu1tured cdls (8). Af, Aß ß; E, 
Eco RI; H, Hind m; Hp, Hpa ß; N, Noo I; Pv, 
A 
4 months of age) with a slower progn:ssion, 
which allowed their breeding. The remaining 
six faunder animals, which wae asymptomatic, 
did not express the transgene (12). Northem 
(RNA) hybridization analysis of the expression 
of the transgene revea1ed RNAs of sizes oorre-
sponding to a total transcript and to bel subge-
nomic mRNA only in the forebrain and in the 
cerebellum of all anima1s with di.sease symp-
toms (Fig. IB). 
In all animals expressing either construct, 
the pathological findings were restricted to 
the central nervous system (CNS) and to the · 
striated muscle. The disease phenotype was 
transmitted to the offspring with a pene-
trance of 100%. Animals with the clinical 
symptoms described above showed variable 
degrees of selective nerve cell degeneration 
in the forebrain, with tissue atrophy and 
reactive gliosis. The areas affected most fre-
quently were the CA3 layer of the hippo-
campus and the telencephalic cortex (Fig. 
2). Some lesions exhibited a moreabnormal 
pattem, with incomplete cortical and sub-
cortical necrosis and occasionally with mac-
rophages and mild lymphocytic infiltrates in 
the meninges and in the perivascular spaces 
(13). In situ hybridization analysis revealed a 
complex pattem of expression in the CNS, 
with groups of neurons, oligodendrocytes, 
and astrocytes containing high amounts of 
transcript in the brain and spinal cord. The 
distribution of positive cells was bilaterally 
symmetrical. In animals 4 weeks ol~ most 
neurons in the CA3 sector of the hippocam-
pus and a subpopulation of cortical neurons 
were strongly positive for HFV RNA, even 
in animals in which onset of symptoms bad 
not yet occurred (Fig. 2A). In sick animals 
older than 6 weeks, most CA3 neurons bad 
degenerated (Fig. 2B}, and the highest Ievels 
of expression were seen in cortical neurons. 
Two pHFV Af and four p4gpe mice 
showed focal degeneration of striated mus-
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Transgenie mice (9) have proved usefu1 in 
the dissection of the pathogenic potential of 
the regulatory genes of the human retrovi-
ruses HfL V -1 and mv ( 10). To analyze the 
biological activity of HFV regulatory pro-
tcins we generared transgenic mice with two 
constructs: (i) pHFV An which contains the 
complete HFV genome in a noninfectious 
Pvu ß. (B) Expression ofHFV-RNA in various B 
tissues of transgenic mia:. Mice 75, 253, 267, 11,0 kb-
and 881 harbor the pAgpe tramgme, and mouse 7,1 kb-
362 is transgmic foc pHFV M- Lancs 1 to 9 wcre 
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from mouse 75: 1ane 1, brain; 1ane 2, liver; 1ane 3, 
lung; 1ane 4, heart; 1ane S, thymus; lane 6, 
kidney; 1ane 7, musde; 1ane 8, lymph nodts; 1ane 
9, spla:n. Lane 10, mousc 362 brain; 1ane 11, 
mouse 253 ttstis; lane 12, mouse 253 brain; 1ane 
13, mousc 267 brain; 1ane 14., nontransgmic 
litn:r~na~e brain; lane 15, nontransgmic Iiner-
mate brain; lane 16, mouse 881 fun:brain; 1ane 
17, mouse 881 parietal and midbrain; lane 18, 
mouse 881 c:erebdlwn and brain stem. 
2,5kb-
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des. These changes ranged from degenera-
tion of single myotubes to large areas of 
myogenic attophy with extensive necroses 
(Fig. 2D). In situ hybridization of cross 
sections of the affected striated musdes dem-
onsttated that expression preceded degener-
ation and was confined to the myotubes. 
Of the organs that did not show patho-
logical changes, ttansgene expression could 
be detected by in situ hybridization in a 
small fraction of retinal intemeurons and in 
a few smooth muscle cells in almost all 
organs analyzed {13). Higher numbers of 
positive cells were detected in the smooth 
musde layer of the digestive tract. 
In addition to the lesions described above, 
the pHFV M transgenic mice showed spotty 
synunetric areas of grayish color in the white 
matter because of severe darnage of the 
myelinated tracts in the anterior commis-
sure, the corpus callosum, the optic nerves, 
the brain stem, the cerebellar white matter, ' 
and, to a lesser extent, in the spinal cord. 
These lesions consisted of fiuid-filled vacu-
oles in the white matter (Fig. 3). lmmuno-
cytochemistry for glial fibrillary acidic pro-
tein (GFAP) revealed a striking reactive 
gliosis in the affected areas, whereas oligo-
dendrocytes showed only occasional swell-
ings. Transgene-expressing cells were invari-
ably dustered in the immediate proximity of 
the lesions. Some of these cells had the 
typical size and structure of oligodendro-
cytes, but a small fraction was identified as 
being composed of astrocytes by combined 
in situ hybridization for HFV RNA and 
immunohistochemistry for GFAP (13). The 
extent and time of onset of these lesions 
varied only slighdy between individual ani-
mals and between families derived from 
distinct founders. 
Flg. 2. Neuronal and muscle pathology in HFV 
transgenic mice (18). (A) In siru hybridization 
with an HFV probe of the hippocampus of a 
4-week-old animal before onset of symptoms. 
Most neurons in the CA3 layer ( arrowheads) 
expressed high Ievels of HFV RNA, whereas the 
CAl area (open arrows) and the dentate gyrus 
(Dg) were essentially negative (hematoxylin-eo-
sin, lOOx). (B) Sclective nerve cell loss in the 
CA3 layer of the hippocampus in a 6-week-old 
animal. The lesioned segment is sharply demar-
cated and corresponds precisely to the area of 
HFV cxpression in the younger animal (Luxol fast 
blue-Nissl stain, lOOx). (C) Frontalcortex fiom a 
7-wcck-old tramgmic animal (GFAP immunohis-
tochemistry, 200x) showing loss of ncurons. Several 
GFAP-positive reactive astrocytes (arrowheads) and 
activatcd miaoglial cells (arrows) are present. (D) 
Paravertebral striated musclcs of a transgenic animal. 
1here is severe myogmic atrophy with siu variation 
of the muscle 6bcrs, i.ncreased number of inremal 
nuclei., loss of aoss-striation, hyaline degeneration of 
the sarcoplasm, and hypertrophy of adjacmt myo-
rubcs. A majority of viable musde 6bers express 
HFVRNA 
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The observation that only a small fraction 
of cells in specific lineages expressed high 
Ievels of transgene RNA, whereas other cells 
of the same lineages were negative, is unusu-
al for ttansgenes conttolled by promoters 
with restricted tissue specificity, such as ret-
roviral LTRs. Mosaicism and positional ef 
fects of the ttansgene integration could bc 
exduded because these observations werc 
confinned in founder animals from 11 inde· 
pendent integration events and in their off. 
spring. Also, we found no evidence fo1 
Flg. 3. White matter lesions. (A) Cross section through the cerebellwn of a 97-day-old pHFV A 
transgenic animal. There is widespread vacuolar degeneration in the white matter of the cerebellum 
(Luxol fast blue-Niss~ 12,5x). (B) HFV expression in the cerebellum of the SaQle animal (in sitll 
hybridization, 50 x). Most cells expressing HFV RNA are located in the white matter and are closel) 
associated with the microcystic changes. Somc positive cells are present in the granular laycr. (C: 
Inununohistochemical demonstration ofmyelin basic protein (MBP) (lOOx). In the immediate vicinit) 
of the vacuoles, MBP immunoreactivity is esscntially preserved and virtua.l.ly no macrophagcs witl: 
myelin degradation products are present, indicating that structuralloss and degradation of myelin hal 
notyet taken place. (D) HFV expression in the anteriorcommissure. Large amounts oftransgenic RN} 
are present in the cells of the anterior commissure but not in the neurons of the surrounding basa 
ganglia (in siru hybridization, 200 x). 
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reversion of the constructs to an infectious 
form or for horiwntal spread of HFV ( 13). It 
is unlikely that expression of the HFV con-
st:ructs depends on the cell cycle because neu-
rons are irreversibly ~ttnitotic in adult ani-
mals. These observations indicate that 
additional, unknown cellular factors may be 
required for high Ievels ofHFV LTR-directed 
transcription. 
Because expression of HFV was predomi-
nantly seen in anatomical structures that will 
eventually degenerate, it is likely that the gene 
products of HFV are directly responsible for 
the observed lesions. However, we are unable 
to identify conclusively which proteins ofHFV 
are responsible for neurotoxicity. Nerve cell 
degeneration was present in animals carrying 
the pägpe DNA, which essentially contains 
only the bel reading frames. A ~ible candi-
date for neurotoxicity is the bel-1 gene product, 
which is fimctionally comparable to the retro-
viral transactivating factors, lllV Mt and 
HILV-I tax (5-7). However, transgerne mice 
carrying LTR Mt and L TR tax develop Ka~i 
sarcomas and peripheral neurogerne and mes-
enchymal tumors, ~pectively ( 10), but no 
degenerative encephalopathy. These differences 
may relate to the tissue-specific expression pat-
tern caused by the HFV cis regulatory elements 
or to different cellular and molecular targets of 
the bel-1 protein. 
The pathologies observed in HFV mice are 
reminiscent of human retroviral disease of the 
CNS: neuronallass and white matter darnage 
are often present in lllV -associated encepha-
lopathy (14) and vacuolarmyelopathy (15) and 
in HILV-I-induced disease ofthe CNS (16). 
The mechanisms of neurotoxicity operaring in 
these conditions may be related to those lead-
ing to neurological darnage in HFV transgerne 
mice. In fact, one of the original isolates of 
HFV was obtained from the brain of a patient 
with a neurodegenerative disease with features 
reminiscentofthe lesions in the HFV mice (2). 
Although a specific pathology has not been 
unequivocally associated with HFV infection, 
and foamyviruses generally have been regarded 
as benign ( 4), detection of HFV in human 
diseases might be problematic if virulence is 
restricted to immunocompromised hosts or to 
abortive forms of infection ( 17). The findings 
described here prompt a critical reappraisal of 
the potential role of HFV as a human patho-
gen. It will be crucial to search for evidence of 
HFV infection, or superinfection, in neurode-
generative and myopathic disorders of un-
known etiology and neurological syndromes in 
immunodeficient patients. 
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Identification of Profilin as a Novel Pollen Allergen; 
IgE Autoreactivity in Sensitized Individuals 
RuooLF V ALENTA, MICHAEL DucH~NE, KAiuN PEITENBURGER, 
CHRISTIAN SILLABER, PETER VALENT, PETER ßETIELHEIM, 
MICHAEL ßREITENBACH, liELMliT RUMPOLD, DIETRICH KRAFr, 
Orro SCHEIN ER* 
A complementary DNA encoding a pollen allergen from white birch (Betula verrvco.sa) 
that was isolated from a pollen complementary DNA library with serum immunoglob-
ulin E from a birch pollen-allergic individual revealed significant sequence homology 
to profilins. The recombinant protein showed high affinity to poly-L-proline. Immu-
noglobulin E antilxxlies from allergic ind.ividuals bound to natural and recombinant 
birch profilin and also to human profilin. In addition, birch and human profilin 
induced histamine release from blood basophils of profilin-allergic individuals, but not 
of individuals sensitized to other plant allergens. The structural similarity of conserved 
proteins might therefore be responsible for maintaining immunoglobulin E antibody 
titers in type I allergy. 
A LLERGIES OF 1HE IMMEDIATE TYPE are a major health problern in indus-trialized countries, where up to 
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15% of the population suffers from type I 
allergic symptoms (rhinitis, conjunctivitis, 
and bronchial asthma). An understanding of 
the complex pathogenetic mechanisms lead-
ing to allergy requires infonnation about the 
strucrure and function of allergerne proteins. 
Comparison of the sequences of doned al-
lergens with those of known proteins has 
already contributed to the charaaerization 
of some allergerne proteins. The major birch 
(Betula vemu:osa) pollen allergen Bet v I {1) 
and the white-faced homet venom allergen 
antigen 5 Dol m V (2) were shown to be 
highly homologous to pathogenesis-related 
plant proteins. The major hou5e dust mite 
allergen Der p I is homologous to proteases-
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